Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2026 10:42 ET | Source: Research and Markets

HERG Screening Market Analysis Report 2026: $3.21 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "HERG Screening Market Report 2026" has been added to ResearchAndMarkets.com's offering. The HERG screening market has seen significant growth,...
May 11, 2026 08:00 ET | Source: AGC Biologics, Inc.

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

The strategic alliance expands existing collaboration and strengthens OTXL’s ability to advance cell and gene therapies for ultra-rare conditions.
May 06, 2026 12:04 ET | Source: CARBOGEN AMCIS INNOVATIONS AG

CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection

CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
May 04, 2026 07:00 ET | Source: Ardena Holding NV.

Ardena Strengthens Executive Team to Drive its Next Phase of Growth

Ardena appoints Ben Ash as CFO and Henny Zijlstra as CCO to strengthen leadership and support global growth across complex drug development services.
May 03, 2026 20:00 ET | Source: AGC Biologics, Inc.

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

AGC Biologics expands its partnership with Novelty Nobility to manufacture a bispecific antibody in Japan.
April 30, 2026 12:00 ET | Source: Research and Markets

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Research Report 2026: Opportunities, Trends, Competitive Landscape, Strategies, Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2026" has been added to ...
April 30, 2026 11:57 ET | Source: Research and Markets

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Research Report 2026: $121 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...
April 30, 2026 11:54 ET | Source: Research and Markets

Peptide and Oligonucleotide CDMO Market Research Report 2026: $4+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Peptide and Oligonucleotide CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The peptide and oligonucleotide DMO...
April 30, 2026 11:38 ET | Source: Research and Markets

Sterile Injectables CDMO Market Research Report 2026: $10.91 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Sterile Injectables CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The sterile injectables CDMO market is...
April 30, 2026 08:00 ET | Source: Integer Holdings Corporation

Integer Announces Strategic Review to Maximize Stockholder Value

PLANO, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today...